2013 Cannabis Clinical Trials Data 
Cannabis Law Report
JULY 27, 2021
His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz, a clinical psychologist, led the development of the ORR as a postdoctoral research fellow at Johns Hopkins University. About Realm of Caring. Lindsey Clarke.
Cannabis Law Report
JUNE 10, 2021
In short the study learns that legalized states tend not to have their roads overcrowded with stoned drivers and cannabis users like alcohol users self police their behaviour. However, relatively few studies have used self-reported data for this purpose [ 11 , 12 , 13 ]. Marijuana policies in the United States (U.S.) Study sample.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MAY 29, 2022
FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. Clinical Trials and Human Subject Protections. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults.
The Cannigma
JUNE 15, 2021
Like all plants, cannabis contains a plethora of molecules, some of which have specific functions — such as determining the smell, taste and color of the plant, but also what types of effects it can have on you. This is why eating raw cannabis won’t necessarily get you high — it is full of non-decarboxylated THCA. CBD vs THC.
Cannabis Law Report
JANUARY 20, 2022
ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Founded in 2013, Eleusis is dedicated to transforming psychedelics into medicines. II is a $287.5 About Eleusis.
Cannabis Law Report
JANUARY 9, 2019
A skeptic all his life, it was not until Martin Tindall walked around a Colorado dispensary and saw firsthand how cannabis could lengthen and save lives did he become a believer. I would never have thought to get into the medical cannabis industry, it always just seemed like an excuse for people to get high,” he told Cannabis Law Report.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Over 1,500 people from around the world attended MAPS’ Psychedelic Science 2013 conference in Oakland, CA. Rick Doblin, Ph.D.,
Expert insights. Personalized for you.
105 
Let's personalize your content